Question:
You are tasked with answering the user's question using the provided context, which includes financial statements (Income Statements, Balance Sheets, and Cash Flow Statements) and financial news articles in multiple languages (English, Chinese, Japanese, Spanish, and Greek). Please provide a detailed and well-supported answer based on the information available. Limit your response to 100 words or fewer. If you cannot answer the question or if no relevant evidence is found, write “None”.

Answer Format:
Answer: {Answer using the financial statement.}
News Evidence: {Verify your answer using quote(s) from the financial news. Write “None” if no news evidence is available.}
Context:
Financial Statements:
| Column 1                                                                      | Column 2              | Column 3   | Column 4   | Column 5   | Column 6   | Column 7   | Column 8   | Column 9   | Column 10   | Column 11   | Column 12   |
|:------------------------------------------------------------------------------|:----------------------|:-----------|:-----------|:-----------|:-----------|:-----------|:-----------|:-----------|:------------|:------------|:------------|
|                                                                               |                       |            |            |            |            |            |            |            |             |             |             |
|                                                                               | December 31,          |            |            |            |            |            |            |            |             |             |             |
| 2024                                                                          |                       | 2023       |            |            |            |            |            |            |             |             |             |
|                                                                               | (Dollars in millions) |            |            |            |            |            |            |            |             |             |             |
| ASSETS                                                                        |                       |            |            |            |            |            |            |            |             |             |             |
| Current assets                                                                |                       |            |            |            |            |            |            |            |             |             |             |
| Cash and cash equivalents                                                     | $                     | 10,567     |            |            | $          | 7,925      |            |            |             |             |             |
| Short-term investments                                                        | 386                   |            |            | 170        |            |            |            |            |             |             |             |
| Accounts receivable, less allowances of $314and $323, respectively            | 7,819                 |            |            | 7,530      |            |            |            |            |             |             |             |
| Inventories                                                                   | 6,442                 |            |            | 6,178      |            |            |            |            |             |             |             |
| Assets held for sale                                                          | 1,365                 |            |            | —          |            |            |            |            |             |             |             |
| Other current assets                                                          | 1,329                 |            |            | 1,699      |            |            |            |            |             |             |             |
| Total current assets                                                          | 27,908                |            |            | 23,502     |            |            |            |            |             |             |             |
| Investments and long-term receivables                                         | 1,394                 |            |            | 939        |            |            |            |            |             |             |             |
| Property, plant and equipment—net                                             | 6,194                 |            |            | 5,660      |            |            |            |            |             |             |             |
| Goodwill                                                                      | 21,825                |            |            | 18,049     |            |            |            |            |             |             |             |
| Other intangible assets—net                                                   | 6,656                 |            |            | 3,231      |            |            |            |            |             |             |             |
| Insurance recoveries for asbestos-related liabilities                         | 171                   |            |            | 170        |            |            |            |            |             |             |             |
| Deferred income taxes                                                         | 238                   |            |            | 392        |            |            |            |            |             |             |             |
| Other assets                                                                  | 10,810                |            |            | 9,582      |            |            |            |            |             |             |             |
| Total assets                                                                  | $                     | 75,196     |            |            | $          | 61,525     |            |            |             |             |             |
| LIABILITIES                                                                   |                       |            |            |            |            |            |            |            |             |             |             |
| Current liabilities                                                           |                       |            |            |            |            |            |            |            |             |             |             |
| Accounts payable                                                              | $                     | 6,880      |            |            | $          | 6,849      |            |            |             |             |             |
| Commercial paper and other short-term borrowings                              | 4,273                 |            |            | 2,085      |            |            |            |            |             |             |             |
| Current maturities of long-term debt                                          | 1,347                 |            |            | 1,796      |            |            |            |            |             |             |             |
| Accrued liabilities                                                           | 8,348                 |            |            | 7,809      |            |            |            |            |             |             |             |
| Liabilities held for sale                                                     | 408                   |            |            | —          |            |            |            |            |             |             |             |
| Total current liabilities                                                     | 21,256                |            |            | 18,539     |            |            |            |            |             |             |             |
| Long-term debt                                                                | 25,479                |            |            | 16,562     |            |            |            |            |             |             |             |
| Deferred income taxes                                                         | 1,787                 |            |            | 2,094      |            |            |            |            |             |             |             |
| Postretirement benefit obligations other than pensions                        | 112                   |            |            | 134        |            |            |            |            |             |             |             |
| Asbestos-related liabilities                                                  | 1,325                 |            |            | 1,490      |            |            |            |            |             |             |             |
| Other liabilities                                                             | 6,076                 |            |            | 6,265      |            |            |            |            |             |             |             |
| Redeemable noncontrolling interest                                            | 7                     |            |            | 7          |            |            |            |            |             |             |             |
| SHAREOWNERS’ EQUITY                                                           |                       |            |            |            |            |            |            |            |             |             |             |
| Capital—common stock issued                                                   | 958                   |            |            | 958        |            |            |            |            |             |             |             |
| —additional paid-in capital                                                   | 9,695                 |            |            | 9,062      |            |            |            |            |             |             |             |
| Common stock held in treasury, at cost                                        | (39,378)              |            |            | (38,008)   |            |            |            |            |             |             |             |
| Accumulated other comprehensive loss                                          | (3,491)               |            |            | (4,135)    |            |            |            |            |             |             |             |
| Retained earnings                                                             | 50,835                |            |            | 47,979     |            |            |            |            |             |             |             |
| Total Honeywell shareowners’ equity                                           | 18,619                |            |            | 15,856     |            |            |            |            |             |             |             |
| Noncontrolling interest                                                       | 535                   |            |            | 578        |            |            |            |            |             |             |             |
| Total shareowners’ equity                                                     | 19,154                |            |            | 16,434     |            |            |            |            |             |             |             |
| Total liabilities, redeemable noncontrolling interest and shareowners’ equity | $                     | 75,196     |            |            | $          | 61,525     |            |            |             |             |             |

---

CONSOLIDATED STATEMENT OF CASH FLOWS

|     |     |     |     |     |     |     |     |     |     |     |     |     |     |     |     |     |     |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
|     |     |     |     |     |     |     |     |     |     |     |     |     |     |     |     |     |     |
|     |     |     | Years Ended December 31, |     |     |     |     |     |     |     |     |     |     |     |     |     |     |
| 2024 |     |     |     |     |     | 2023 |     |     |     |     |     | 2022 |     |     |
|     |     |     | (Dollars in millions) |     |     |     |     |     |     |     |     |     |     |     |     |     |     |
| Cash flows from operating activities |     |     |     |     |     |     |     |     |     |     |     |     |     |     |     |     |     |
| Net income |     |     | $   | 5,740 |     |     |     |     | $   | 5,672 |     |     |     |     | $   | 4,967 |     |
| Less: Net income attributable to noncontrolling interest |     |     | 35  |     |     |     |     |     | 14  |     |     |     |     |     | 1   |     |     |
| Net income attributable to Honeywell |     |     | 5,705 |     |     |     |     |     | 5,658 |     |     |     |     |     | 4,966 |     |     |
| Adjustments to reconcile net income attributable to Honeywell to net cash provided by operating activities |     |     |     |     |     |     |     |     |     |     |     |     |     |     |     |     |     |
| Depreciation |     |     | 671 |     |     |     |     |     | 659 |     |     |     |     |     | 657 |     |     |
| Amortization |     |     | 663 |     |     |     |     |     | 517 |     |     |     |     |     | 547 |     |     |
| Loss (gain) on sale of non-strategic businesses and assets |     |     | 1   |     |     |     |     |     | (5) |     |     |     |     |     | (22) |     |     |
| Impairment of assets held for sale |     |     | 219 |     |     |     |     |     | —   |     |     |     |     |     | —   |     |     |
| Repositioning and other charges |     |     | 244 |     |     |     |     |     | 860 |     |     |     |     |     | 1,266 |     |     |
| Net payments for repositioning and other charges |     |     | (479) |     |     |     |     |     | (459) |     |     |     |     |     | (512) |     |     |
| NARCO Buyout payment |     |     | —   |     |     |     |     |     | (1,325) |     |     |     |     |     | —   |     |     |
| Pension and other postretirement income |     |     | (476) |     |     |     |     |     | (406) |     |     |     |     |     | (510) |     |     |
| Pension and other postretirement benefit payments |     |     | (32) |     |     |     |     |     | (38) |     |     |     |     |     | (23) |     |     |
| Stock compensation expense |     |     | 194 |     |     |     |     |     | 202 |     |     |     |     |     | 188 |     |     |
| Deferred income taxes |     |     | (233) |     |     |     |     |     | 153 |     |     |     |     |     | (180) |     |     |
|     |     |     |     |     |     |     |     |     |     |     |     |     |     |     |     |     |     |
| Other |     |     | (617) |     |     |     |     |     | (837) |     |     |     |     |     | (358) |     |     |
| Changes in assets and liabilities, net of the effects of acquisitions and divestitures |     |     |     |     |     |     |     |     |     |     |     |     |     |     |     |     |     |
| Accounts receivable |     |     | (96) |     |     |     |     |     | (42) |     |     |     |     |     | (739) |     |     |
| Inventories |     |     | (304) |     |     |     |     |     | (626) |     |     |     |     |     | (440) |     |     |
| Other current assets |     |     | 371 |     |     |     |     |     | 17  |     |     |     |     |     | 232 |     |     |
| Accounts payable |     |     | 95  |     |     |     |     |     | 518 |     |     |     |     |     | (155) |     |     |
| Accrued liabilities |     |     | 171 |     |     |     |     |     | 494 |     |     |     |     |     | 357 |     |     |
| Net cash provided by operating activities |     |     | 6,097 |     |     |     |     |     | 5,340 |     |     |     |     |     | 5,274 |     |     |
| Cash flows from investing activities |     |     |     |     |     |     |     |     |     |     |     |     |     |     |     |     |     |
| Capital expenditures |     |     | (1,164) |     |     |     |     |     | (1,039) |     |     |     |     |     | (766) |     |     |
| Proceeds from disposals of property, plant and equipment |     |     | —   |     |     |     |     |     | 43  |     |     |     |     |     | 29  |     |     |
| Increase in investments |     |     | (1,077) |     |     |     |     |     | (560) |     |     |     |     |     | (1,211) |     |     |
| Decrease in investments |     |     | 870 |     |     |     |     |     | 971 |     |     |     |     |     | 1,255 |     |     |
| Receipts from Garrett Motion Inc. |     |     | —   |     |     |     |     |     | —   |     |     |     |     |     | 409 |     |     |
| Receipts from settlements of derivative contracts |     |     | 94  |     |     |     |     |     | 6   |     |     |     |     |     | 369 |     |     |
| Cash paid for acquisitions, net of cash acquired |     |     | (8,880) |     |     |     |     |     | (718) |     |     |     |     |     | (178) |     |     |
| Proceeds from sales of businesses, net of fees paid |     |     | —   |     |     |     |     |     | 4   |     |     |     |     |     | —   |     |     |
| Net cash used for investing activities |     |     | (10,157) |     |     |     |     |     | (1,293) |     |     |     |     |     | (93) |     |     |
| Cash flows from financing activities |     |     |     |     |     |     |     |     |     |     |     |     |     |     |     |     |     |
| Proceeds from issuance of commercial paper and other short-term borrowings |     |     | 13,838 |     |     |     |     |     | 12,991 |     |     |     |     |     | 7,661 |     |     |
| Payments of commercial paper and other short-term borrowings |     |     | (11,578) |     |     |     |     |     | (13,663) |     |     |     |     |     | (8,447) |     |     |
| Proceeds from issuance of common stock |     |     | 537 |     |     |     |     |     | 196 |     |     |     |     |     | 320 |     |     |
| Proceeds from issuance of long-term debt |     |     | 10,408 |     |     |     |     |     | 2,986 |     |     |     |     |     | 2,953 |     |     |
| Payments of long-term debt |     |     | (1,812) |     |     |     |     |     | (1,731) |     |     |     |     |     | (1,850) |     |     |
| Repurchases of common stock |     |     | (1,655) |     |     |     |     |     | (3,715) |     |     |     |     |     | (4,200) |     |     |
| Cash dividends paid |     |     | (2,902) |     |     |     |     |     | (2,855) |     |     |     |     |     | (2,719) |     |     |
|     |     |     |     |     |     |     |     |     |     |     |     |     |     |     |     |     |     |
|     |     |     |     |     |     |     |     |     |     |     |     |     |     |     |     |     |     |
| Other |     |     | 3   |     |     |     |     |     | 28  |     |     |     |     |     | (48) |     |     |
| Net cash provided by (used for) financing activities |     |     | 6,839 |     |     |     |     |     | (5,763) |     |     |     |     |     | (6,330) |     |     |
| Effect of foreign exchange rate changes on cash and cash equivalents |     |     | (137) |     |     |     |     |     | 14  |     |     |     |     |     | (183) |     |     |
| Net increase (decrease) in cash and cash equivalents |     |     | 2,642 |     |     |     |     |     | (1,702) |     |     |     |     |     | (1,332) |     |     |
| Cash and cash equivalents at beginning of period |     |     | 7,925 |     |     |     |     |     | 9,627 |     |     |     |     |     | 10,959 |     |     |
| Cash and cash equivalents at end of period |     |     | $   | 10,567 |     |     |     |     | $   | 7,925 |     |     |     |     | $   | 9,627 |     |

---

| Column 1                                                 | Column 2                                       | Column 3   | Column 4   | Column 5   | Column 6   | Column 7   | Column 8   | Column 9   | Column 10   | Column 11   | Column 12   | Column 13   | Column 14   | Column 15   | Column 16   | Column 17   | Column 18   |
|:---------------------------------------------------------|:-----------------------------------------------|:-----------|:-----------|:-----------|:-----------|:-----------|:-----------|:-----------|:------------|:------------|:------------|:------------|:------------|:------------|:------------|:------------|:------------|
|                                                          |                                                |            |            |            |            |            |            |            |             |             |             |             |             |             |             |             |             |
|                                                          | Years Ended December 31,                       |            |            |            |            |            |            |            |             |             |             |             |             |             |             |             |             |
| 2024                                                     |                                                | 2023       |            | 2022       |            |            |            |            |             |             |             |             |             |             |             |             |             |
|                                                          | (Dollars in millions,except per share amounts) |            |            |            |            |            |            |            |             |             |             |             |             |             |             |             |             |
| Product sales                                            | $                                              | 26,279     |            |            | $          | 25,773     |            |            | $           | 25,960      |             |             |             |             |             |             |             |
| Service sales                                            | 12,219                                         |            |            | 10,889     |            |            | 9,506      |            |             |             |             |             |             |             |             |             |             |
| Net sales                                                | 38,498                                         |            |            | 36,662     |            |            | 35,466     |            |             |             |             |             |             |             |             |             |             |
| Costs, expenses and other                                |                                                |            |            |            |            |            |            |            |             |             |             |             |             |             |             |             |             |
| Cost of products sold                                    | 17,227                                         |            |            | 16,977     |            |            | 16,955     |            |             |             |             |             |             |             |             |             |             |
| Cost of services sold                                    | 6,609                                          |            |            | 6,018      |            |            | 5,392      |            |             |             |             |             |             |             |             |             |             |
| Total Cost of products and services sold                 | 23,836                                         |            |            | 22,995     |            |            | 22,347     |            |             |             |             |             |             |             |             |             |             |
| Research and development expenses                        | 1,536                                          |            |            | 1,456      |            |            | 1,478      |            |             |             |             |             |             |             |             |             |             |
| Selling, general and administrative expenses             | 5,466                                          |            |            | 5,127      |            |            | 5,214      |            |             |             |             |             |             |             |             |             |             |
| Impairment of assets held for sale                       | 219                                            |            |            | —          |            |            | —          |            |             |             |             |             |             |             |             |             |             |
| Other (income) expense                                   | (830)                                          |            |            | (840)      |            |            | (366)      |            |             |             |             |             |             |             |             |             |             |
| Interest and other financial charges                     | 1,058                                          |            |            | 765        |            |            | 414        |            |             |             |             |             |             |             |             |             |             |
| Total costs, expenses and other                          | 31,285                                         |            |            | 29,503     |            |            | 29,087     |            |             |             |             |             |             |             |             |             |             |
| Income before taxes                                      | 7,213                                          |            |            | 7,159      |            |            | 6,379      |            |             |             |             |             |             |             |             |             |             |
| Tax expense                                              | 1,473                                          |            |            | 1,487      |            |            | 1,412      |            |             |             |             |             |             |             |             |             |             |
| Net income                                               | 5,740                                          |            |            | 5,672      |            |            | 4,967      |            |             |             |             |             |             |             |             |             |             |
| Less: Net income attributable to noncontrolling interest | 35                                             |            |            | 14         |            |            | 1          |            |             |             |             |             |             |             |             |             |             |
| Net income attributable to Honeywell                     | $                                              | 5,705      |            |            | $          | 5,658      |            |            | $           | 4,966       |             |             |             |             |             |             |             |
| Earnings per share of common stock—basic                 | $                                              | 8.76       |            |            | $          | 8.53       |            |            | $           | 7.33        |             |             |             |             |             |             |             |
| Earnings per share of common stock—assuming dilution     | $                                              | 8.71       |            |            | $          | 8.47       |            |            | $           | 7.27        |             |             |             |             |             |             |             |

---

English News:
**Honeywell Reports Annual Financial Performance with Enhanced Earnings Amid Strategic Investments** Honeywell International Inc. has unveiled its financial results for the fiscal year ending December 31, 2024, demonstrating robust growth despite challenges in some segments. The company reported net sales of $38.5 billion, marking a 5% increase over the prior year. This growth was mainly fueled by increased sales volumes, strategic pricing adjustments, and significant contributions from recent acquisitions. However, the Industrial Automation segment experienced a 7% decline in sales. The company's net income attributable to Honeywell reached $5.7 billion, translating to earnings per share (EPS) of $8.71, an improvement from the previous year's EPS of $8.47. The enhanced earnings were supported by a gross margin increase to 38.1%, up from 37.3% in the previous year. On the investment front, Honeywell's cash flow statement reveals substantial activity, with cash paid for acquisitions totaling $8.88 billion. This significant outlay was a primary driver for the net cash outflow from investing activities, which amounted to $10.157 billion for the year. This strategic investment underscores Honeywell's commitment to enhancing its growth trajectory through acquisitions and partnerships. Overall, Honeywell's financial performance highlights a strong year marked by strategic investments and improved profitability, despite sector-specific challenges. The company's focus on growth through acquisitions and efficiency improvements appears to be yielding positive results.

Chinese News:
霍尼韦尔披露分拆计划：拟成立三家独立上市公司 美国当地时间2月6日，霍尼韦尔（HON.US）通过重大业务调整计划，其董事会已完成由董事长兼首席执行官柯伟茂（Vimal Kapur）一年前启动的全面业务组合评估，并计划分拆自动化和航空航天业务。 《中国经营报》记者从霍尼韦尔方面获悉，此次分拆，加上之前已宣布剥离的高性能材料业务，霍尼韦尔将成立三家独立上市企业。分拆计划将于2026年下半年完成。 柯伟茂（Vimal Kapur）表示，此举将释放巨大价值，为每家公司量身制订增长战略。同日，霍尼韦尔还公布了2024年第四季度和全年业绩：全年实现销售额384.98亿美元，同比增长5%，并预计2025年的销售额为396亿至406亿美元，内生式销售额同比增长2%至5%。 分拆上市 2024年10月，霍尼韦尔宣布计划将其高性能材料业务分拆为一家独立的美国上市公司，该业务预计于2025年年底或2026年年初完成。 加上此次分拆的自动化和航空航天业务，霍尼韦尔将成立三家独立上市企业。 对于此次的分拆细节，霍尼韦尔方面表示，自动化和航空航天业务的分拆计划预计以对霍尼韦尔股东免税的方式实现，并计划于2026年下半年完成，但须符合某些惯例条件。 上述分拆计划发布后，霍尼韦尔的股价在2月7日下跌2.05%，收于205.520美元。 霍尼韦尔方面表示，2025年，其将计划投入至少250亿美元用于高回报资本支出、股息、机会性股票购买和增值收购，在分拆过程中继续其业务组合的转型，以增强每项业务的价值主张。 记者了解到，分拆完成后，霍尼韦尔成立的三家独立上市公司包括霍尼韦尔自动化、霍尼韦尔航空航天、霍尼韦尔高性能材料。 其中，霍尼韦尔自动化将聚焦能源安全、可持续到数字化、人工智能领域，2024年营收约为180亿美元；霍尼韦尔航空航天目标成为最大的独立上市的航空航天供应商之一，2024年营收超150亿美元；霍尼韦尔高性能材料专注于可持续发展的特种化学品和材料业务，专注于氟产品、电子材料、工业级纤维和医疗包装解决方案领域，2024年营收近40亿美元。 2024年销售额超380亿美元 在宣布上述分拆计划的同日，霍尼韦尔还公布了2024年第四季度和全年业绩。 财报数据显示，霍尼韦尔2024年全年实现销售额384.98亿美元，同比增长5%。 此外，霍尼韦尔2024年全年每股收益为8.71美元，同比增长3%。调整后每股收益增长4%，至9.89美元。 霍尼韦尔方面提到，尽管宏观经济仍面临挑战，但公司的未交货订单增长了11%，达到创纪录的353亿美元。 同时，霍尼韦尔还公布了2025年业绩展望。霍尼韦尔预计2025年的销售额为396亿至406亿美元，内生式销售额同比增长2%至5%。部门利润率预计将在23.2%至23.6%，部门利润率增长60至100个基点。调整后每股收益预计为10.1至10.5美元之间，同比增长2%至6%。运营现金流预计为67亿至71亿美元，自由现金流为54亿至58亿美元。

Japanese News:
ハネウェル・インターナショナル（Honeywell International Inc.）は2024年第4四半期の決算を発表し、収益とEPS（調整後1株当たり利益）が予想を上回ったものの、自動化と航空宇宙部門の事業分割計画を発表したことで株価が下落しました。 決算結果： 売上高: 100.9億ドル、前年同期比7％増（有機的には2％増）、市場予想の98.3億ドルを上回った。 営業利益率: 17.3％、前年同期比50ベーシスポイント（BPS）増加。 セグメント利益率: 20.9％、前年同期比350ベーシスポイント減少。 調整後EPS: 2.47ドル、前年同期比8％増、予想の2.32ドルを上回った。 営業キャッシュフロー: 22.8億ドル、フリーキャッシュフロー: 18.9億ドル。 現金および流動資産: 約109億ドル（2024年12月31日時点）。 部門別売上： 航空宇宙技術: 39.9億ドル、前年同期比9％増。 産業用自動化: 25.7億ドル、前年同期比1％減。 建物用途自動化: 18.0億ドル、前年同期比20％増。 エネルギー・持続可能ソリューション: 17.3億ドル、前年同期比4％増。 2025会計年度見通し： 売上高予想: 39.6億ドル〜40.6億ドル、オーガニック売上高成長率は2％〜5％の範囲。 調整後EPS予想: 10.10ドル〜10.50ドル、前年同期比で7〜10％増加。 フリーキャッシュフロー予想: 54億ドル〜58億ドル。 営業キャッシュフロー予想: 67億ドル〜71億ドル。 事業分割計画： ハネウェルは、自社の取締役会が自動化と航空宇宙の事業部門を分割する計画を進めていることを明らかにしました。この分割により、Honeywell Automation、Honeywell Aerospace、Advanced Materialsの3つの公開企業が設立されます。この分割は2026年下半期に完了予定で、株主にとっては非課税の構造となります。 コメント： Vimal Kapur最高経営責任者（CEO）は、「2024年、私たちはHoneywellのポートフォリオを最適化し、重要な戦略的買収を通じて、我々の成長を促進しています。これからも高リターンの資本支出、配当、株買い取り、および買収を通じて、引き続き価値を創造していきます」と述べました。

Spanish News:
Honeywell ha anunciado su decisión de dividirse en tres compañías cotizadas de manera independiente, lo que incluirá la separación de sus negocios de automatización, tecnología aeroespacial y materiales avanzados. Este movimiento responde a una estrategia de crecimiento diferenciada para cada área y se espera que la escisión de Honeywell Automation y Honeywell Aerospace se complete de manera libre de impuestos para los accionistas en la segunda mitad de 2026. La separación del negocio de materiales avanzados está prevista para finales de 2025 o principios de 2026. Estrategia de crecimiento y perspectivas: Honeywell ha confirmado que las tres empresas independientes estarán adecuadamente capitalizadas y contarán con la flexibilidad financiera para aprovechar futuras oportunidades de crecimiento. La compañía aseguró que las empresas segregadas mantendrán una escala global y destacaron que Honeywell Automation alcanzó ingresos de 18.000 millones de dólares en 2024, mientras que Honeywell Aerospace facturó 15.000 millones de dólares. La división de materiales avanzados registró una cifra de negocio de casi 4.000 millones de dólares. La decisión de dividir la empresa llega tras la presión del inversor activista Elliott Investment Management, que en noviembre reveló una posición de más de 5.000 millones de dólares en Honeywell y pidió una escisión debido al bajo rendimiento de las acciones, en parte debido a la estructura de conglomerado de la empresa. Resultados anuales de 2024: En 2024, Honeywell reportó un beneficio neto atribuido de 5.705 millones de dólares, un aumento del 0,8% en comparación con el año anterior. Las ventas netas alcanzaron los 38.498 millones de dólares, lo que representa un crecimiento del 5%, impulsado por un avance del 2% en la comercialización de productos y un aumento del 12,2% en la venta de servicios. En el cuarto trimestre de 2024, Honeywell registró un beneficio neto atribuido de 1.285 millones de dólares, un 1,7% más que en el mismo período de 2023, mientras que las ventas netas alcanzaron los 10.088 millones de dólares, un incremento del 6,9%. Perspectivas para 2025: Honeywell ha actualizado sus expectativas para 2025, proyectando una cifra de negocio neta de entre 39.600 y 40.600 millones de dólares, lo que implica un crecimiento orgánico de entre el 2% y el 5% respecto a 2024. Además, espera un beneficio por acción ajustado de entre 10,10 y 10,50 dólares, lo que representaría una mejora anual de entre el 2% y el 6%. Declaraciones de Vimal Kapur: Vimal Kapur, presidente y CEO de Honeywell, comentó: "Hemos cerrado un año exitoso, superando nuestras previsiones de ventas y ganancias ajustadas por acción del cuarto trimestre, a pesar de un entorno operativo dinámico. Estoy convencido de que nuestra estrategia de optimización de la cartera y nuestra sólida base nos permitirán crear aún más valor para nuestros accionistas, clientes y empleados en 2025".

Greek News:
Η Honeywell υπέβαλε, στις 14 Φεβρουαρίου 2025, την ετήσια έκθεση 10-K για το οικονομικό έτος που έληξε στις 31 Δεκεμβρίου 2024, σύμφωνα με τις απαιτήσεις αναφοράς της Επιτροπής Κεφαλαιαγοράς των ΗΠΑ (SEC), βάσει των Τμημάτων 13 και 15(d) του Νόμου περί Χρηματιστηριακών Συναλλαγών. Η υποβολή της εταιρείας περιλάμβανε συνολικά 216 ξεχωριστά έγγραφα. Ανάμεσά τους συγκαταλέγονται η κύρια Φόρμα 10-K σε μορφή iXBRL, πολυάριθμα παραρτήματα, συμφωνίες με στελέχη, πιστοποιήσεις, καθώς και περισσότερα από 50 υποστηρικτικά γραφικά αρχεία. Όλα τα στοιχεία εντάσσονται στο πλαίσιο της συμμόρφωσης με τις απαιτήσεις διαφάνειας και πληροφόρησης προς τους επενδυτές. Η έκθεση καλύπτει την οικονομική και επιχειρησιακή απόδοση της Honeywell για τη διάρκεια του 2024, περιλαμβάνοντας αναλυτικά οικονομικά δεδομένα με σήμανση XBRL, τα οποία συνδέονται με την καταχώριση της εταιρείας στην SEC υπό τον Κωδικό Κεντρικού Αναγνωριστικού (CIK) 0000773840.

Question:
What is the company's R&D ratio (R&D divided by revenue)? Please provide only the final result(s); do not include any calculation steps. Please quote the piece(s) of news aligned with the finding(s), if any.

Answer:

Question: What is the company's R&D ratio (R&D divided by revenue)? Please provide only the final result(s); do not include any calculation steps. Please quote the piece(s) of news aligned with the finding(s), if any.


Question:
You are tasked with answering the user's question using the provided context, which includes financial statements (Income Statements, Balance Sheets, and Cash Flow Statements) and financial news articles in multiple languages (English, Chinese, Japanese, Spanish, and Greek). Please provide a detailed and well-supported answer based on the information available. Limit your response to 100 words or fewer. If you cannot answer the question or if no relevant evidence is found, write “None”.

Answer Format:
Answer: {Answer using the financial statement.}
News Evidence: {Verify your answer using quote(s) from the financial news. Write “None” if no news evidence is available.}
Context:
Financial Statements:
| Column 1                                                                      | Column 2              | Column 3   | Column 4          | Column 5   | Column 6   | Column 7   | Column 8   | Column 9   | Column 10   | Column 11   | Column 12   |
|:------------------------------------------------------------------------------|:----------------------|:-----------|:------------------|:-----------|:-----------|:-----------|:-----------|:-----------|:------------|:------------|:------------|
|                                                                               |                       |            |                   |            |            |            |            |            |             |             |             |
|                                                                               | March 31, 2025        |            | December 31, 2024 |            |            |            |            |            |             |             |             |
|                                                                               | (Dollars in millions) |            |                   |            |            |            |            |            |             |             |             |
| ASSETS                                                                        |                       |            |                   |            |            |            |            |            |             |             |             |
| Current assets                                                                |                       |            |                   |            |            |            |            |            |             |             |             |
| Cash and cash equivalents                                                     | $                     | 9,657      |                   |            | $          | 10,567     |            |            |             |             |             |
| Short-term investments                                                        | 402                   |            |                   | 386        |            |            |            |            |             |             |             |
| Accounts receivable, less allowances of $353and $314, respectively            | 8,251                 |            |                   | 7,819      |            |            |            |            |             |             |             |
| Inventories                                                                   | 6,611                 |            |                   | 6,442      |            |            |            |            |             |             |             |
| Assets held for sale                                                          | 1,393                 |            |                   | 1,365      |            |            |            |            |             |             |             |
| Other current assets                                                          | 1,331                 |            |                   | 1,329      |            |            |            |            |             |             |             |
| Total current assets                                                          | 27,645                |            |                   | 27,908     |            |            |            |            |             |             |             |
| Investments and long-term receivables                                         | 1,418                 |            |                   | 1,394      |            |            |            |            |             |             |             |
| Property, plant and equipment—net                                             | 6,213                 |            |                   | 6,194      |            |            |            |            |             |             |             |
| Goodwill                                                                      | 22,021                |            |                   | 21,825     |            |            |            |            |             |             |             |
| Other intangible assets—net                                                   | 6,537                 |            |                   | 6,656      |            |            |            |            |             |             |             |
| Insurance recoveries for asbestos-related liabilities                         | 167                   |            |                   | 171        |            |            |            |            |             |             |             |
| Deferred income taxes                                                         | 229                   |            |                   | 238        |            |            |            |            |             |             |             |
| Other assets                                                                  | 10,988                |            |                   | 10,810     |            |            |            |            |             |             |             |
| Total assets                                                                  | $                     | 75,218     |                   |            | $          | 75,196     |            |            |             |             |             |
| LIABILITIES                                                                   |                       |            |                   |            |            |            |            |            |             |             |             |
| Current liabilities                                                           |                       |            |                   |            |            |            |            |            |             |             |             |
| Accounts payable                                                              | $                     | 6,734      |                   |            | $          | 6,880      |            |            |             |             |             |
| Commercial paper and other short-term borrowings                              | 5,756                 |            |                   | 4,273      |            |            |            |            |             |             |             |
| Current maturities of long-term debt                                          | 1,332                 |            |                   | 1,347      |            |            |            |            |             |             |             |
| Accrued liabilities                                                           | 7,849                 |            |                   | 8,348      |            |            |            |            |             |             |             |
| Liabilities held for sale                                                     | 400                   |            |                   | 408        |            |            |            |            |             |             |             |
| Total current liabilities                                                     | 22,071                |            |                   | 21,256     |            |            |            |            |             |             |             |
| Long-term debt                                                                | 25,744                |            |                   | 25,479     |            |            |            |            |             |             |             |
| Deferred income taxes                                                         | 1,750                 |            |                   | 1,787      |            |            |            |            |             |             |             |
| Postretirement benefit obligations other than pensions                        | 110                   |            |                   | 112        |            |            |            |            |             |             |             |
| Asbestos-related liabilities                                                  | 1,283                 |            |                   | 1,325      |            |            |            |            |             |             |             |
| Other liabilities                                                             | 6,229                 |            |                   | 6,076      |            |            |            |            |             |             |             |
| Redeemable noncontrolling interest                                            | 7                     |            |                   | 7          |            |            |            |            |             |             |             |
| SHAREOWNERS’ EQUITY                                                           |                       |            |                   |            |            |            |            |            |             |             |             |
| Capital—common stock issued                                                   | 958                   |            |                   | 958        |            |            |            |            |             |             |             |
| —additional paid-in capital                                                   | 9,943                 |            |                   | 9,695      |            |            |            |            |             |             |             |
| Common stock held in treasury, at cost                                        | (41,200)              |            |                   | (39,378)   |            |            |            |            |             |             |             |
| Accumulated other comprehensive loss                                          | (3,788)               |            |                   | (3,491)    |            |            |            |            |             |             |             |
| Retained earnings                                                             | 51,550                |            |                   | 50,835     |            |            |            |            |             |             |             |
| Total Honeywell shareowners’ equity                                           | 17,463                |            |                   | 18,619     |            |            |            |            |             |             |             |
| Noncontrolling interest                                                       | 561                   |            |                   | 535        |            |            |            |            |             |             |             |
| Total shareowners’ equity                                                     | 18,024                |            |                   | 19,154     |            |            |            |            |             |             |             |
| Total liabilities, redeemable noncontrolling interest and shareowners’ equity | $                     | 75,218     |                   |            | $          | 75,196     |            |            |             |             |             |

---

| Column 1                                                                                | Column 2                     | Column 3   | Column 4   | Column 5   | Column 6   | Column 7   | Column 8   | Column 9   | Column 10   | Column 11   | Column 12   |
|:-----------------------------------------------------------------------------------------------------------|:-----------------------------|:-----------|:-----------|:-----------|:-----------|:-----------|:-----------|:-----------|:------------|:------------|:------------|
|                                                                                |                              |            |            |            |            |            |            |            |             |             |             |
|                                                                                | Three Months Ended March 31, |            |            |            |            |            |            |            |             |             |             |
|                                                                                | 2025                         |            | 2024       |            |            |            |            |            |             |             |             |
|                                                                                | (Dollars in millions)        |            |            |            |            |            |            |            |             |             |             |
| Cash flows from operating activities                                                                       |                              |            |            |            |            |            |            |            |             |             |             |
| Net income                                                                                | $                            | 1,467      |            |            | $          | 1,475      |            |            |             |             |             |
| Less: Net income attributable to noncontrolling interest                                                   | 18                           |            |            | 12         |            |            |            |            |             |             |             |
| Net income attributable to Honeywell                                                                       | 1,449                        |            |            | 1,463      |            |            |            |            |             |             |             |
| Adjustments to reconcile net income attributable to Honeywell to net cash provided by operating activities |                              |            |            |            |            |            |            |            |             |             |             |
| Depreciation                                                                                | 174                          |            |            | 166        |            |            |            |            |             |             |             |
| Amortization                                                                                | 200                          |            |            | 125        |            |            |            |            |             |             |             |
| Gain on sale of non-strategic businesses and assets                                                        | (16)                         |            |            | —          |            |            |            |            |             |             |             |
| Impairment of assets held for sale                                                                         | 15                           |            |            | —          |            |            |            |            |             |             |             |
| Repositioning and other charges                                                                            | 45                           |            |            | 93         |            |            |            |            |             |             |             |
| Net payments for repositioning and other charges                                                           | (104)                        |            |            | (124)      |            |            |            |            |             |             |             |
|                                                                                |                              |            |            |            |            |            |            |            |             |             |             |
| Pension and other postretirement income                                                                    | (145)                        |            |            | (151)      |            |            |            |            |             |             |             |
| Pension and other postretirement benefit payments                                                          | (5)                          |            |            | (8)        |            |            |            |            |             |             |             |
| Stock compensation expense                                                                                | 61                           |            |            | 53         |            |            |            |            |             |             |             |
| Deferred income taxes                                                                                | (19)                         |            |            | 3          |            |            |            |            |             |             |             |
| Other                                                                                | (196)                        |            |            | (158)      |            |            |            |            |             |             |             |
| Changes in assets and liabilities, net of the effects of acquisitions and divestitures                     |                              |            |            |            |            |            |            |            |             |             |             |
| Accounts receivable                                                                                | (424)                        |            |            | 53         |            |            |            |            |             |             |             |
| Inventories                                                                                | (181)                        |            |            | (140)      |            |            |            |            |             |             |             |
| Other current assets                                                                                | 35                           |            |            | 63         |            |            |            |            |             |             |             |
| Accounts payable                                                                                | (149)                        |            |            | (381)      |            |            |            |            |             |             |             |
| Accrued liabilities                                                                                | (123)                        |            |            | (565)      |            |            |            |            |             |             |             |
| Income taxes                                                                                | (20)                         |            |            | (44)       |            |            |            |            |             |             |             |
| Net cash provided by operating activities                                                                  | 597                          |            |            | 448        |            |            |            |            |             |             |             |
| Cash flows from investing activities                                                                       |                              |            |            |            |            |            |            |            |             |             |             |
| Capital expenditures                                                                                | (251)                        |            |            | (233)      |            |            |            |            |             |             |             |
| Proceeds from disposals of property, plant and equipment                                                   | 23                           |            |            | —          |            |            |            |            |             |             |             |
| Increase in investments                                                                                | (351)                        |            |            | (238)      |            |            |            |            |             |             |             |
| Decrease in investments                                                                                | 338                          |            |            | 155        |            |            |            |            |             |             |             |
| (Payments) receipts from settlements of derivative contracts                                               | (125)                        |            |            | 43         |            |            |            |            |             |             |             |
| Cash paid for acquisitions, net of cash acquired                                                           | (5)                          |            |            | —          |            |            |            |            |             |             |             |
|                                                                                |                              |            |            |            |            |            |            |            |             |             |             |
| Net cash used for investing activities                                                                     | (371)                        |            |            | (273)      |            |            |            |            |             |             |             |
| Cash flows from financing activities                                                                       |                              |            |            |            |            |            |            |            |             |             |             |
| Proceeds from issuance of commercial paper and other short-term borrowings                                 | 4,855                        |            |            | 2,223      |            |            |            |            |             |             |             |
| Payments of commercial paper and other short-term borrowings                                               | (3,413)                      |            |            | (2,470)    |            |            |            |            |             |             |             |
| Proceeds from issuance of common stock                                                                     | 42                           |            |            | 144        |            |            |            |            |             |             |             |
| Proceeds from issuance of long-term debt                                                                   | 46                           |            |            | 5,710      |            |            |            |            |             |             |             |
| Payments of long-term debt                                                                                | (44)                         |            |            | (573)      |            |            |            |            |             |             |             |
| Repurchases of common stock                                                                                | (1,902)                      |            |            | (671)      |            |            |            |            |             |             |             |
| Cash dividends paid                                                                                | (732)                        |            |            | (703)      |            |            |            |            |             |             |             |
| Other                                                                                | (32)                         |            |            | 36         |            |            |            |            |             |             |             |
| Net cash (used for) provided by financing activities                                                       | (1,180)                      |            |            | 3,696      |            |            |            |            |             |             |             |
| Effect of foreign exchange rate changes on cash and cash equivalents                                       | 44                           |            |            | (40)       |            |            |            |            |             |             |             |
| Net (decrease) increase in cash and cash equivalents                                                       | (910)                        |            |            | 3,831      |            |            |            |            |             |             |             |
| Cash and cash equivalents at beginning of period                                                           | 10,567                       |            |            | 7,925      |            |            |            |            |             |             |             |
| Cash and cash equivalents at end of period                                                                 | $                            | 9,657      |            |            | $          | 11,756     |            |            |             |             |             |

---

| Column 1                                                 | Column 2   | Column 3   | Column 4                     | Column 5   | Column 6                                        | Column 7   | Column 8   | Column 9   | Column 10   | Column 11   | Column 12   | Column 13   | Column 14   | Column 15   | Column 16   |
|:---------------------------------------------------------|:-----------|:-----------|:-----------------------------|:-----------|:------------------------------------------------|:-----------|:-----------|:-----------|:------------|:------------|:------------|:------------|:------------|:------------|:------------|
|                                                          |            |            |                              |            |                                                 |            |            |            |             |             |             |             |             |             |             |
|                                                          |            |            | Three Months Ended March 31, |            |                                                 |            |            |            |             |             |             |             |             |             |             |
|                                                          |            |            |                              | 2025       |                                                 | 2024       |            |            |             |             |             |             |             |             |             |
|                                                          |            |            |                              |            | (Dollars in millions, except per share amounts) |            |            |            |             |             |             |             |             |             |             |
| Product sales                                            |            |            |                              |            | $                                               | 6,645      |            |            | $           | 6,263       |             |             |             |             |             |
| Service sales                                            |            |            |                              |            | 3,177                                           |            |            | 2,842      |             |             |             |             |             |             |             |
| Net sales                                                |            |            |                              |            | 9,822                                           |            |            | 9,105      |             |             |             |             |             |             |             |
| Costs, expenses and other                                |            |            |                              |            |                                                 |            |            |            |             |             |             |             |             |             |             |
| Cost of products sold                                    |            |            |                              |            | 4,251                                           |            |            | 4,035      |             |             |             |             |             |             |             |
| Cost of services sold                                    |            |            |                              |            | 1,786                                           |            |            | 1,548      |             |             |             |             |             |             |             |
| Total Cost of products and services sold                 |            |            |                              |            | 6,037                                           |            |            | 5,583      |             |             |             |             |             |             |             |
| Research and development expenses                        |            |            |                              |            | 439                                             |            |            | 360        |             |             |             |             |             |             |             |
| Selling, general and administrative expenses             |            |            |                              |            | 1,361                                           |            |            | 1,302      |             |             |             |             |             |             |             |
| Impairment of assets held for sale                       |            |            |                              |            | 15                                              |            |            | —          |             |             |             |             |             |             |             |
| Other (income) expense                                   |            |            |                              |            | (200)                                           |            |            | (231)      |             |             |             |             |             |             |             |
| Interest and other financial charges                     |            |            |                              |            | 286                                             |            |            | 220        |             |             |             |             |             |             |             |
| Total costs, expenses and other                          |            |            |                              |            | 7,938                                           |            |            | 7,234      |             |             |             |             |             |             |             |
| Income before taxes                                      |            |            |                              |            | 1,884                                           |            |            | 1,871      |             |             |             |             |             |             |             |
| Tax expense                                              |            |            |                              |            | 417                                             |            |            | 396        |             |             |             |             |             |             |             |
| Net income                                               |            |            |                              |            | 1,467                                           |            |            | 1,475      |             |             |             |             |             |             |             |
| Less: Net income attributable to noncontrolling interest |            |            |                              |            | 18                                              |            |            | 12         |             |             |             |             |             |             |             |
| Net income attributable to Honeywell                     |            |            |                              |            | $                                               | 1,449      |            |            | $           | 1,463       |             |             |             |             |             |
| Earnings per share of common stock—basic                 |            |            |                              |            | $                                               | 2.24       |            |            | $           | 2.24        |             |             |             |             |             |
| Earnings per share of common stock—assuming dilution     |            |            |                              |            | $                                               | 2.22       |            |            | $           | 2.23        |             |             |             |             |             |

---

English News:
**Honeywell International Reports Stable Q1 Earnings with Slight Dip in Net Income** Honeywell International has reported its financial results for the first quarter of 2025, showing a slight decrease in net income. The company's net income for the period fell to $1,467 million, a minor decline from the $1,475 million reported in the same period of 2024. This marginal drop reflects a stable financial performance amid a challenging economic landscape. The first quarter also saw changes in Honeywell's cash position, with cash and cash equivalents reducing to $9,657 million at the end of March 2025, from $10,567 million at the end of December 2024. This decline is largely attributed to substantial common stock repurchases alongside cash dividends issued during the quarter. These actions suggest a strategic focus on returning value to shareholders despite the impact on cash reserves. Moreover, the company's balance sheet revealed a reduction in total equity, which decreased from $19,154 million at the close of 2024 to $18,024 million by March 2025. This reduction is primarily driven by the repurchase of common stock and accumulated other comprehensive losses, highlighting Honeywell's ongoing shareholder-focused capital allocation strategy. Overall, Honeywell's financial results for the first quarter of 2025 exhibit a largely stable performance, with strategic decisions aimed at shareholder returns influencing certain key metrics. As the year progresses, the company will likely continue to balance its investment in growth opportunities with shareholder value initiatives.

Chinese News:
霍尼韦尔第一季度业绩超预期 调整后每股收益2.51美元同比增长7% 霍尼韦尔周二公布了第一季度的业绩，在所有指标上均超过了公司的指导值。该公司还维持了其全年有机增长指导，提高了调整后每股收益指导范围，并重申了其自由现金流指导范围。该公司报告称，第一季度销售额同比增长8%，有机销售额增长4%，其中国防和航天以及建筑解决方案连续第二个季度实现两位数的有机销售额增长。营业利润率收缩30个基点至20.1%，部门利润率持平于23.0%，高于之前的指引。营业利润增长6%，分部利润1增长8%，达到23亿美元，这得益于收购的贡献和对卓越商业的持续关注。第一季度每股收益为2.22美元，与去年同期持平，调整后每股收益为2.51美元，同比增长7%。经营现金流为6亿美元，自由现金流1为3亿美元，同比增长61%。

Japanese News:
ハネウェル・インターナショナル（Honeywell International Inc.）は2025年第1四半期の決算を発表し、調整後1株当たり利益（EPS）が2.51ドルとなり、予想の2.21ドルを上回った。同社の売上高は98.2億ドルで、予想の96億ドルをわずかに下回った。発表後、ハネウェルの株価は4.96%上昇し、投資家の前向きな反応を示した。 主なポイント： ハネウェルの調整後EPSは予想を13.6%上回った。 同社の株価はプレマーケット取引で4.96%上昇した。 オーガニック売上高は4%増加し、航空宇宙部門とビル自動化部門の好調な業績に牽引された。 ハネウェルは年初から約30億ドル相当の自社株買いを実施した。 同社は3つの上場企業への戦略的分割計画を発表した。 企業業績： ハネウェルは2025年第1四半期に堅調な業績を示し、オーガニック売上高は4%増加、セグメント利益は前年同期比8%増加した。航空宇宙部門がオーガニック売上高9%増で成長を牽引し、商業アフターマーケットは15%の伸びを記録した。同社はセグメント利益率を前年と同じ23%に維持した。 財務ハイライト： 売上高：98.2億ドル、予想をわずかに下回る。 調整後EPS：2.51ドル、前年同期比7%増。 受注高：106億ドル、前年比3%増。 フリーキャッシュフロー：3億ドル超、前年から改善。 実績対予想： ハネウェルの実際のEPS 2.51ドルは予想の2.21ドルを13.6%上回り、大幅なプラスのサプライズとなった。この業績は、市場の不確実性にもかかわらず、同社のコスト管理能力と主要セグメントでの成長を反映している。 市場の反応： 決算発表後、ハネウェルの株価は4.96%上昇し、210.62ドルの新水準に達した。この動きにより、同社の株価は52週高値の242.77ドルに近づき、同社の将来性に対する投資家の強い信頼を示している。 見通しとガイダンス： 通年について、ハネウェルはオーガニック売上高の成長率を2%から5%の間と予想し、調整後EPSは10.2ドルから10.5ドルの範囲になると見込んでいる。同社はフリーキャッシュフローを54億ドルから58億ドルと予測している。航空宇宙部門は高単位の一桁成長を維持すると予想される一方、産業オートメーションは中単位の一桁減少に直面する可能性がある。 経営陣のコメント： ヴィマル・カプール最高経営責任者（CEO）は、「我々はこの不確実な時期に、収益を保護するだけでなく成長させ、将来に投資し、ハネウェルを長期的な成功に向けて位置づけるための決定的な行動を取っている」と述べた。マイク・ステプニアク最高財務責任者（CFO）は、「我々は年間のオーガニック売上高成長率を2%から5%とする従来の見通しを維持している」と付け加えた。 リスクと課題： 関税エクスポージャー：2025年に約5億ドル、主に産業オートメーションと航空宇宙部門に影響。 中国市場の不確実性：産業オートメーションにおける課題が成長に影響を与える可能性。 短期サイクル事業の需要：需要の潜在的な変動による慎重な見方。 グローバル貿易パターン：関税の増加による変化が国際事業に影響を与える可能性。 分割戦略：3つの上場企業への計画的分割に関連する実行リスク。 質疑応答： 決算説明会では、アナリストらは関税の影響とハネウェルのこれらのコストを軽減するための戦略について質問した。同社は価格調整と生産性向上を通じて関税費用を相殺することに自信を示した。さらに、アナリストらは短期サイクル事業の需要見通しについて質問し、ハネウェルは防衛および航空宇宙アフターマーケットサービスにおける継続的な強さを引用しながら、慎重ながらも楽観的な見方を示した。

Spanish News:
Honeywell (NASDAQ: HON) publicó el martes sus resultados del primer trimestre, registrando beneficios e ingresos que superaron las expectativas de los analistas, además de confirmar sus previsiones para todo el año. La compañía reportó un beneficio por acción (BPA) de 2,51 dólares, por encima de la estimación de consenso de 2,21 dólares. Los ingresos del período crecieron un 8% interanual, alcanzando los 9.820 millones de dólares, superando también las expectativas de 9.600 millones de dólares. En las operaciones previas a la apertura del mercado estadounidense, las acciones de Honeywell subieron un 5%. Resultados clave: Ventas orgánicas: Aumento del 4% interanual, superando la estimación de crecimiento del 1,47%. División Aeroespacial: Registró ingresos de 4.170 millones de dólares, superando los 4.050 millones de dólares proyectados. Automatización Industrial: Los ingresos fueron de 2.380 millones de dólares, ligeramente por encima de los 2.370 millones de dólares estimados. Flujo de caja libre: Totalizó 346 millones de dólares, por debajo de los 515,8 millones de dólares esperados por los analistas. Declaraciones de Vimal Kapur, presidente y CEO de Honeywell: "Honeywell comenzó el año de manera excepcional, superando las previsiones en todos los indicadores, liderado por un sólido crecimiento orgánico", comentó Kapur. "Aunque aún no lo hemos reflejado en nuestros resultados, sabemos que enfrentamos un entorno de demanda global incierto para el resto de 2025. Trabajaremos incansablemente para cumplir con las expectativas de nuestros clientes y accionistas". Perspectivas para 2025: BPA proyectado: La compañía mantuvo su rango de previsión de BPA entre 10,20 y 10,50 dólares, frente a una estimación de consenso de 10,37 dólares. Ingresos: Honeywell actualizó ligeramente su perspectiva de ingresos, proyectando entre 39.600 millones y 40.500 millones de dólares, comparado con el rango anterior de 39.600 millones a 40.600 millones de dólares. La proyección de consenso se sitúa en 40.340 millones de dólares. Crecimiento de ventas orgánicas: Se espera un crecimiento entre el 2% y el 5%, frente a las estimaciones del 3,88%. Flujo de caja libre: La compañía reiteró su objetivo de flujo de caja libre entre 5.400 millones y 5.800 millones de dólares, frente a los 5.420 millones de dólares esperados.

Greek News:
Η Honeywell ανακοίνωσε καθαρές πωλήσεις ύψους 9,82 δισεκατομμυρίων δολαρίων για το πρώτο τρίμηνο του οικονομικού έτους, σημειώνοντας αύξηση 8% σε σύγκριση με τα 9,11 δισεκατομμύρια δολάρια της αντίστοιχης περυσινής περιόδου. Η άνοδος αυτή υποστηρίχθηκε από αύξηση 2% στον όγκο πωλήσεων, 2% στις τιμές και 5% μέσω εξαγορών, ενώ η οργανική ανάπτυξη αντισταθμίστηκε εν μέρει από αρνητική συναλλαγματική επίδραση κατά 1%. Παράλληλα, η εταιρεία ενίσχυσε τις επενδύσεις της στην καινοτομία, αυξάνοντας τις δαπάνες για έρευνα και ανάπτυξη στα 439 εκατομμύρια δολάρια, έναντι 360 εκατομμυρίων ένα χρόνο πριν. Η αύξηση αυτή οφείλεται κυρίως σε στοχευμένες επενδύσεις στον τομέα των Τεχνολογιών Αεροδιαστημικής. Ωστόσο, τα οικονομικά αποτελέσματα επηρεάστηκαν από χρέωση απομείωσης 15 εκατομμυρίων δολαρίων που σχετίζεται με περιουσιακά στοιχεία προς πώληση στη δραστηριότητα Εξοπλισμού Ατομικής Προστασίας (PPE). Το ποσό αυτό ενσωματώθηκε στις συνολικές χρηματοοικονομικές χρεώσεις και τόκους, οι οποίοι ανήλθαν στα 286 εκατομμύρια δολάρια. Παρά τις σχετικές επιβαρύνσεις, τα απομειωμένα κέρδη ανά μετοχή διαμορφώθηκαν σταθερά στα 2,22 δολάρια, σε σύγκριση με το αντίστοιχο τρίμηνο του προηγούμενου έτους.

Question:
What trends can be observed in the company’s revenue amount over the past few years? Please quote the piece(s) of news aligned with the finding(s), if any.

Answer:

Question: What trends can be observed in the company’s revenue amount over the past few years? Please quote the piece(s) of news aligned with the finding(s), if any.